Fundz

Ryne Biotechnology reported raising $3 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEJul 20, 2022$3M of $5M raised

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale Jun 13, 2022)

Round Type

Seed

CambridgeBiotechnologyHealth CareTherapeutics

Quick answer

RYNE Biotechnology raised $3 Million in a Seed round, dated June 13, 2022. RYNE Biotechnology is based in Cambridge, Massachusetts, United States.

How much did RYNE Biotechnology raise?
RYNE Biotechnology raised $3 Million in a Seed round on June 13, 2022.
What does RYNE Biotechnology do?
Kenai Therapeutics is also known as Ryne Biotechnology.
Where is RYNE Biotechnology based and how big is it?
RYNE Biotechnology is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at RYNE Biotechnology?
Fundz holds 1 contact at RYNE Biotechnology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as RYNE Biotechnology that raised within 45 days of this round, from Fundz verified event records.

  • Vicinitas Therapeutics raised $65M (Series A) on July 28, 2022.
  • Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
  • Biofrontera raised $7.1M on July 27, 2022.
  • Iveric Bio raised an undisclosed amount (Debt Financing) on July 26, 2022.
  • Genetika+ raised an undisclosed amount (Funding Round) on July 26, 2022.
  • Camp4 Therapeutics Corp raised $100M (Series B) on July 20, 2022.

Who to call at RYNE Biotechnology, and when

A new round usually means RYNE Biotechnology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day RYNE Biotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RYNE Biotechnology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RYNE Biotechnology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RYNE Biotechnology

Location

ONE BROADWAY

Cambridge, Massachusetts, United States

About

Kenai Therapeutics is also known as Ryne Biotechnology. Ryne Bio is a biotechnology company pioneering next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology, a Nobel-winning breakthrough that enables scientists to manufacture any human cell, in order to advance Ryne Bio’s off-the-shelf neuron replacement therapeutics. By focusing on an iPSC technology platform, and forging partnerships with global leaders in surgical delivery and clinical development, Ryne Bio is dedicated to advancing a best-in-class pipeline targeting neurological diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RYNE Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts4 people are listed at RYNE Biotechnology. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for RYNE Biotechnology's next move

See what Strategic adds

RYNE Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.